Reduction in camera-specific variability in [123I]FP-CIT SPECT outcome measures by image reconstruction optimized for multisite settings: impact on age-dependence of the specific binding ratio in the ENC-DAT database of healthy controls

PurposeQuantitative estimates of dopamine transporter availability, determined with [123I]FP-CIT SPECT, depend on the SPECT equipment, including both hardware and (reconstruction) software, which limits their use in multicentre research and clinical routine. This study tested a dedicated reconstruction algorithm for its ability to reduce camera-specific intersubject variability in [123I]FP-CIT SPECT. The secondary aim was to evaluate binding in whole brain (excluding striatum) as a reference for quantitative analysis.MethodsOf 73 healthy subjects from the European Normal Control Database of [123I]FP-CIT recruited at six centres, 70 aged between 20 and 82 years were included. SPECT images were reconstructed using the QSPECT software package which provides fully automated detection of the outer contour of the head, camera-specific correction for scatter and septal penetration by transmission-dependent convolution subtraction, iterative OSEM reconstruction including attenuation correction, and camera-specific “to kBq/ml” calibration. LINK and HERMES reconstruction were used for head-to-head comparison. The specific striatal [123I]FP-CIT binding ratio (SBR) was computed using the Southampton method with binding in the whole brain, occipital cortex or cerebellum as the reference. The correlation between SBR and age was used as the primary quality measure.ResultsThe fraction of SBR variability explained by age was highest (1) with QSPECT, independently of the reference region, and (2) with whole brain as the reference, independently of the reconstruction algorithm.ConclusionQSPECT reconstruction appears to be useful for reduction of camera-specific intersubject variability of [123I]FP-CIT SPECT in multisite and single-site multicamera settings. Whole brain excluding striatal binding as the reference provides more stable quantitative estimates than occipital or cerebellar binding.

[1]  H. Iida,et al.  Quantitative assessment of regional myocardial blood flow with thallium-201 and SPECT , 1998, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[2]  John Seibyl,et al.  SNM Practice Guideline for Dopamine Transporter Imaging with 123I-Ioflupane SPECT 1.0* , 2012, The Journal of Nuclear Medicine.

[3]  K. Ogawa,et al.  Compton scatter compensation using the triple-energy window method for single- and dual-isotope SPECT. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[4]  E.-S. Kim,et al.  Multiperiodic states and bifurcations in bunch lengthening by a localized impedance in electron storage ring , 2001 .

[5]  Dag Aarsland,et al.  Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies. , 2004, Archives of neurology.

[6]  Stefan Eberl,et al.  Multicenter Evaluation of a Standardized Protocol for Rest and Acetazolamide Cerebral Blood Flow Assessment Using a Quantitative SPECT Reconstruction Program and Split-Dose 123I-Iodoamphetamine , 2010, The Journal of Nuclear Medicine.

[7]  R. C. Oldfield The assessment and analysis of handedness: the Edinburgh inventory. , 1971, Neuropsychologia.

[8]  H Amthauer,et al.  Global scaling for semi-quantitative analysis in FP-CIT SPECT , 2014, Nuklearmedizin.

[9]  H. Iida,et al.  SPECT collimator dependency of scatter and validation of transmission dependent scatter compensation methodologies , 2000, 2000 IEEE Nuclear Science Symposium. Conference Record (Cat. No.00CH37149).

[10]  Markus Nowak Lonsdale,et al.  Calibration of gamma camera systems for a multicentre European 123I-FP-CIT SPECT normal database , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[11]  Z Walker,et al.  Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic presynaptic ligand , 2002, Journal of neurology, neurosurgery, and psychiatry.

[12]  D. Jennings,et al.  Optimized, Automated Striatal Uptake Analysis Applied to SPECT Brain Scans of Parkinson's Disease Patients , 2007, Journal of Nuclear Medicine.

[13]  I. McKeith,et al.  Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study , 2007, The Lancet Neurology.

[14]  D. Bailey,et al.  A transmission-dependent method for scatter correction in SPECT. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[15]  Perry E Radau,et al.  Clinical testing of an optimized software solution for an automated, observer-independent evaluation of dopamine transporter SPECT studies. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[16]  John S. Fleming,et al.  Quantification of [123I]FP-CIT SPECT brain images: an accurate technique for measurement of the specific binding ratio , 2006, European Journal of Nuclear Medicine and Molecular Imaging.

[17]  K. Tatsch,et al.  Quantitative approaches to dopaminergic brain imaging. , 2012, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

[18]  John S Fleming,et al.  The specific uptake size index for quantifying radiopharmaceutical uptake. , 2004, Physics in medicine and biology.

[19]  Osama Sabri,et al.  Value of Semiquantitative Analysis for Clinical Reporting of 123I-2-β-Carbomethoxy-3β-(4-Iodophenyl)-N-(3-Fluoropropyl)Nortropane SPECT Studies , 2013, The Journal of Nuclear Medicine.

[20]  K. Ogawa,et al.  A practical method for position-dependent Compton-scatter correction in single photon emission CT. , 1991, IEEE transactions on medical imaging.

[21]  Hidehiro Iida,et al.  Reproducibility of Cerebral Blood Flow Assessment using a Quantitative SPECT Reconstruction Program and Split-Dose 123I-Iodoamphetamine in Institutions with Different γ-Cameras and Collimators , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[22]  J D Speelman,et al.  [123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease. , 1997, Journal of neurology, neurosurgery, and psychiatry.

[23]  Kenji Ishida,et al.  Three-dimensional brain phantom containing bone and grey matter structures with a realistic head contour , 2012, Annals of Nuclear Medicine.

[24]  Koen Van Laere,et al.  EANM procedure guidelines for brain neurotransmission SPECT using 123I-labelled dopamine transporter ligands, version 2 , 2010, European Journal of Nuclear Medicine and Molecular Imaging.

[25]  Jan Booij,et al.  The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism , 2001, European Journal of Nuclear Medicine.

[26]  S Eberl,et al.  Effects of scatter and attenuation correction on quantitative assessment of regional cerebral blood flow with SPECT. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[27]  J B Habraken,et al.  Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[28]  D. Guilloteau,et al.  Visualization of the Dopamine Transporter in the Human Brain Postmortem with the New Selective Ligand [125I]PE2I , 1999, NeuroImage.

[29]  H Iida,et al.  Monte Carlo and experimental evaluation of accuracy and noise properties of two scatter correction methods for SPECT , 1996, Physics in medicine and biology.

[30]  Stefan Eberl,et al.  Design and experimental validation of a quantitative myocardial /sup 201/Tl SPECT system , 1998 .

[31]  J. Darcourt,et al.  Automatic semi-quantification of [123I]FP-CIT SPECT scans in healthy volunteers using BasGan version 2: results from the ENC-DAT database , 2013, European Journal of Nuclear Medicine and Molecular Imaging.

[32]  Klaus Tatsch,et al.  Nigrostriatal Dopamine Terminal Imaging with Dopamine Transporter SPECT: An Update , 2013, The Journal of Nuclear Medicine.

[33]  Wim Vandenberghe,et al.  The cost effectiveness of 123I-FP-CIT SPECT imaging in patients with an uncertain clinical diagnosis of parkinsonism , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[34]  H. Malcolm Hudson,et al.  Accelerated image reconstruction using ordered subsets of projection data , 1994, IEEE Trans. Medical Imaging.

[35]  K. Laere,et al.  European multicentre database of healthy controls for [123I]FP-CIT SPECT (ENC-DAT): age-related effects, gender differences and evaluation of different methods of analysis , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[36]  P. Armitage,et al.  Statistical methods in medical research. , 1972 .

[37]  L S Graham,et al.  Quantitation of SPECT performance: Report of Task Group 4, Nuclear Medicine Committee. , 1995, Medical physics.